Charles Magness
Directeur/Bestuurslid bij Kineta One LLC
Vermogen: 397 064 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Charles Magness
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Illumigen Biosciences, Inc.
Illumigen Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Illumigen Biosciences, Inc. provides pharmaceutical research services. It develops human genetic mutations that provide roadmap for therapeutic drug mechanisms. The company's product IB657 helps to investigate the cause of apparent immunity to HCV infection. Illumigen Biosciences was founded by Dr. Charles Magness and Shawn Iadonato in 2000 and is located in Seattle, WA
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Charles Magness via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
University of Pennsylvania | College/University | Undergraduate Degree | |
Kineta Immuno-Oncology LLC
Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA. | Biotechnology | Chief Executive Officer | |
Kineta Viral Hemorrhagic Fever LLC
Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Kineta Chronic Pain LLC
Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
CBI CO., LTD. | Auto Parts: OEM | Director/Board Member | |
KINETA, INC. | Pharmaceuticals: Major | Founder |
Statistieken
Internationaal
Verenigde Staten | 10 |
Zuid-Korea | 2 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Producer Manufacturing | 2 |
Operationeel
Director/Board Member | 7 |
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 1 |
Sterkste connecties
Insiders | |
---|---|
Shawn Iadonato | 11 |
- Beurs
- Insiders
- Charles Magness
- Bedrijfsconnecties